ABL Bio (Korea) Odds of Future Stock Price Finishing Under 24537.63

298380 Stock  KRW 25,050  1,000.00  4.16%   
ABL Bio's future price is the expected price of ABL Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ABL Bio performance during a given time horizon utilizing its historical volatility. Check out ABL Bio Backtesting, ABL Bio Valuation, ABL Bio Correlation, ABL Bio Hype Analysis, ABL Bio Volatility, ABL Bio History as well as ABL Bio Performance.
  
Please specify ABL Bio's target price for which you would like ABL Bio odds to be computed.

ABL Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ABL Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ABL Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ABL Bio generated a negative expected return over the last 90 days
ABL Bio has high historical volatility and very poor performance
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations.
Roughly 32.0% of the company shares are owned by insiders or employees

ABL Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ABL Stock often depends not only on the future outlook of the current and potential ABL Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABL Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding47.1 M
Cash And Short Term Investments43.6 B
Shares Float28 M

ABL Bio Technical Analysis

ABL Bio's future price can be derived by breaking down and analyzing its technical indicators over time. ABL Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ABL Bio. In general, you should focus on analyzing ABL Stock price patterns and their correlations with different microeconomic environments and drivers.

ABL Bio Predictive Forecast Models

ABL Bio's time-series forecasting models is one of many ABL Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ABL Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ABL Bio

Checking the ongoing alerts about ABL Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ABL Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ABL Bio generated a negative expected return over the last 90 days
ABL Bio has high historical volatility and very poor performance
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations.
Roughly 32.0% of the company shares are owned by insiders or employees

Other Information on Investing in ABL Stock

ABL Bio financial ratios help investors to determine whether ABL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABL with respect to the benefits of owning ABL Bio security.